Shafiq Nusrat, Singh Meenu, Kaur Sharonjeet, Khosla Pratibha, Malhotra Samir
Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India, 160012.
Cochrane Database Syst Rev. 2010 Jan 20(1):CD001918. doi: 10.1002/14651858.CD001918.pub2.
A cholesterol-lowering diet and several other dietary interventions have been suggested as a management approach either independently or as an adjuvant to drug therapy in children and adults with familial hypercholesterolemia. However, a consensus has yet to be reached on the most appropriate dietary treatment.
To examine whether a cholesterol-lowering diet is more effective in reducing ischaemic heart disease and lowering cholesterol than no dietary intervention in children and adults with familial hypercholesterolaemia. Further, to compare the efficacy of supplementing a cholesterol-lowering diet with either omega-3 fatty acids, soya proteins, plant sterols or plant stanols.
We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Inborn Errors of Metabolism Trials Register.Most recent search of the Group's Inborn Errors of Metabolism Trials Register: 09 October 2009.We also searched PubMed till 01 June 2008.
Randomised controlled trials, both published and unpublished, where a cholesterol-lowering diet in children and adults with familial hypercholesterolaemia has been compared to other forms of dietary treatment or to no dietary intervention were included.
Two authors independently assessed the trial eligibility and methodological quality and one extracted the data, with independent verification of data extraction by a colleague.
In the present update, four new trials have been added making eleven trials with a total of 331 participants eligible for inclusion. Only short-term outcomes could be assessed due to the short duration of follow up in the included studies. None of the primary outcomes, (incidence of ischaemic heart disease, number of deaths and age at death) were evaluated in any of the included studies. No significant difference was noted for the majority of secondary outcomes for any of the planned comparisons. However, a significant difference was found only for the following comparison and outcome: total cholesterol levels for the comparison between plant sterols and cholesterol-lowering diet, mean difference 0.70 (95% confidence interval 0.19 to 1.21).
AUTHORS' CONCLUSIONS: No conclusions can be made about the effectiveness of a cholesterol-lowering diet, or any of the other dietary interventions suggested for familial hypercholesterolaemia, due to the lack of adequate data. Large, parallel, randomised controlled trials are needed to investigate the effectiveness of a cholesterol-lowering diet and the addition of omega-3 fatty acids, plant sterols or stanols, soya protein to a cholesterol-lowering diet.
对于家族性高胆固醇血症的儿童和成人,已有人提出采用降胆固醇饮食及其他几种饮食干预措施作为一种管理方法,可单独使用,也可作为药物治疗的辅助手段。然而,对于最合适的饮食治疗方法尚未达成共识。
研究在家族性高胆固醇血症的儿童和成人中,降胆固醇饮食在降低缺血性心脏病风险和降低胆固醇方面是否比不进行饮食干预更有效。此外,比较在降胆固醇饮食中添加ω-3脂肪酸、大豆蛋白、植物甾醇或植物甾烷醇的疗效。
我们检索了Cochrane囊性纤维化和遗传疾病小组先天性代谢缺陷试验注册库。该小组先天性代谢缺陷试验注册库的最新检索时间为2009年10月9日。我们还检索了截至2008年6月1日的PubMed。
纳入已发表和未发表的随机对照试验,这些试验比较了家族性高胆固醇血症儿童和成人的降胆固醇饮食与其他形式的饮食治疗或不进行饮食干预的情况。
两位作者独立评估试验的合格性和方法学质量,一位作者提取数据,由一位同事独立核实数据提取情况。
在本次更新中,新增了四项试验,共有11项试验、331名参与者符合纳入标准。由于纳入研究的随访时间较短,只能评估短期结果。纳入的任何研究均未评估任何主要结局(缺血性心脏病发病率、死亡人数和死亡年龄)。对于任何计划中的比较,大多数次要结局均未发现显著差异。然而,仅在以下比较和结局中发现了显著差异:植物甾醇与降胆固醇饮食比较的总胆固醇水平,平均差异为0.70(95%置信区间为0.19至1.21)。
由于缺乏足够的数据,无法就降胆固醇饮食或家族性高胆固醇血症建议的任何其他饮食干预措施的有效性得出结论。需要进行大规模、平行、随机对照试验来研究降胆固醇饮食以及在降胆固醇饮食中添加ω-3脂肪酸、植物甾醇或甾烷醇、大豆蛋白的有效性。